~~<i id='3800236F45'><strike id='3800236F45'><tt id='3800236F45'><pre id='3800236F45'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：fashion 2025-10-02 12:31:42 - browse：78862

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： 4th of July breaks record for highest global temperature ever measured

knowledge

leisure time

hotspot

knowledge

entertainment

explore

Morethan75,000KaiserPermanentehealthcareworkershavevotedtoauthorizeastrikeifthetwosidescan'treachade

WSS

STAT Virtual Event: Putting AI to the Test

Experts study whether long Covid risk adds up with each reinfection

It's been 20 years since Dolly the sheep. Where's my clone?

Doctor appointment wait times are getting worse

Listen: Biogen's messy board & Laronde's data problem

Hearing on Medicare drug price negotiation gets unusually heated

hotspot

Wikipedia

knowledge

How one medical school became remarkably diverse

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Peter Hotez and the public health issue of online harassment

How AI helped researchers track recovery from depression

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lasker Awards 2023: Winners in biomedical research

Novavax promises a turnaround & Lilly roils the obesity market

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

BioMarin wins approval for gene therapy to treat hemophilia A

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

leisure time

Drug for rare kidney disease narrowly misses mark in clinical trial

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Option Care buys Amedisys in $3.6 billion home care deal

Lasker Awards 2023: Winners in biomedical research

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

hotspot

knowledge

entertainment

explore